Helicobacter pylori infection. Helicobacter pylori [H. pylori] as the cause of diseases classified elsewhere
Conditions
Interventions
Intervention 1: Intervention group: Patients in this group are treated with a quadruple regimen for 2 weeks: 1. Levofloxacin 500 mg twice daily 2. Bismuth subcitrate 120 mg four times daily 3. Amoxici
Sponsors
Sabzevar University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Age over 18 years Helicobacter pylori infection in urea breath test Patients with symptoms of dyspepsia Patients who underwent upper endoscopy and had a positive rapid urease test.
Exclusion criteria
Exclusion criteria: Pregnancy Unwillingness to enter the study Previous history of allergy to any medication Patients who have previously been treated for Helicobacter pylori infection. Patients who have been taking Proton-pump inhibitors (PPIs) or antibiotics for the past 4 weeks
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Helicobacter pylori infection. Timepoint: At the beginning of the study (before the intervention) and 4 weeks after starting the treatment. Method of measurement: Endoscopic biopsy and urea breathing test. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMohammad Sahebkar
Sabzevar University of Medical Sciences
Outcome results
None listed